Molecules (Dec 2022)

Enzymatic Synthesis of Vancomycin-Modified DNA

  • Chiara Figazzolo,
  • Frédéric Bonhomme,
  • Saidbakhrom Saidjalolov,
  • Mélanie Ethève-Quelquejeu,
  • Marcel Hollenstein

DOI
https://doi.org/10.3390/molecules27248927
Journal volume & issue
Vol. 27, no. 24
p. 8927

Abstract

Read online

Many potent antibiotics fail to treat bacterial infections due to emergence of drug-resistant strains. This surge of antimicrobial resistance (AMR) calls in for the development of alternative strategies and methods for the development of drugs with restored bactericidal activities. In this context, we surmised that identifying aptamers using nucleotides connected to antibiotics will lead to chemically modified aptameric species capable of restoring the original binding activity of the drugs and hence produce active antibiotic species that could be used to combat AMR. Here, we report the synthesis of a modified nucleoside triphosphate equipped with a vancomycin moiety on the nucleobase. We demonstrate that this nucleotide analogue is suitable for polymerase-mediated synthesis of modified DNA and, importantly, highlight its compatibility with the SELEX methodology. These results pave the way for bacterial-SELEX for the identification of vancomycin-modified aptamers.

Keywords